LOU064
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for LOU064, covering 2021-04-27 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up [Phase 3]